Joseph Michael Scandura
Associate Professor of Medicine · Weill Medical College, New York Presbyterian Hospital
Credentials: · · · · · ·
History
- 1987
Cornell Ithaca
Research
DNA methylation of the first exon is tightly linked to transcriptional silencing
PLoS ONE · 2011 · Last of 7 authors · Corresponding · 483 citations
Somatic mutations and cell identity linked by Genotyping of Transcriptomes
Nature · 2019 · 266 citations
Proceedings of the National Academy of Sciences of the United States of America · 2004 · First of 4 authors · 209 citations
17 papers · 1 as a fellow
15 papers
13 papers
11 papers
9 papers
7 papers
6 papers
5 papers
Grants
- 2025–2029
Controlling the Niche to Control Clonal Hematopoiesis
National Heart, Lung, and Blood Institute · R01
Contact PI · $1.6M · Weill Medical Coll of Cornell Univ
- 2014–2016
Promoting Hematopoietic Regeneration After Chemo by Rescheduling Homeostasis
National Heart, Lung, and Blood Institute · R56
Contact PI · $546.6K · Weill Medical Coll of Cornell Univ
- 2012–2014
Genome-Wide Identification of DNA Methylation Biomarkers in AML
National Cancer Institute · R21
Contact PI · $409.8K · Weill Medical Coll of Cornell Univ
- 2005–2010
p57KIP2 in Hematopoiesis and Leukemogenesis
National Cancer Institute · K08
Contact PI · $673.5K · Weill Medical Coll of Cornell Univ
Clinical trials
- 2019–2024
Principal investigator · Terminated · Phase 2
Weill Medical College of Cornell University
- 2011–2027
Principal investigator · Active not recruiting · Phase 2
National Cancer Institute (NCI)
- 2007–2009
Phase I Epigenetic Priming Using Decitabine With Induction Chemotherapy in AML
Principal investigator · Completed · Phase 1
Weill Medical College of Cornell University
- 2024–2027
An Extension Study for Patients Previously Enrolled in Studies With Pelabresib
Site PI · Recruiting · Phase 3
Novartis Pharmaceuticals